Shanghai company that grew from rehabilitation robots into humanoids; its GR-3 is a care-focused full-size 'Care-bot' humanoid.
Where it stands: Jan 2026: Fourier says it has served over 2,000 medical institutions and enterprise clients in 40+ countries (mainly rehabilitation robots); GR-3 sales timing not published. source
36Kr (May 2026) reports Fourier has entered listing preparation after an early-2025 Series E backed by investors including SoftBank and IDG Capital, at a valuation of about 8 billion yuan; no filing date given. source
A small companion robot concept shown at CES 2026 alongside GR-3, sharing its design language and personality. Fourier says it is still in development and is meant to be dressed and personalised like a collectible figure, pointing the company's care-robot ideas toward a cheaper consumer format. No specifications or launch timing have been published.
Fourier's first full-size 'Care-bot', a humanoid built for companionship and care rather than factory work. A multimodal system combines vision, hearing and touch so it can locate voices, follow people and respond to touch, while a hybrid controller pairs fast reflexes with language-model reasoning. First shown in August 2025; US debut at CES 2026.
Second-generation general-purpose humanoid, an upgrade of the GR-1 that Fourier billed as the world's first mass-produced humanoid. Aimed at researchers and developers, it adds 12-joint dexterous hands with tactile sensors, a detachable battery and an SDK compatible with ROS, NVIDIA Isaac Lab and MuJoCo.